Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket

Shares of GlucoTrack Inc (NASDAQ: GCTK) rose sharply in pre-market trading following the announcement that its subsidiary, Lokahi Therapeutics, signed its first external, fee-for-service partnership. Innovate GBM, a nonprofit dedicated to glioblastoma research, engaged two of Lokahi’s ai PIPELINE project teams to identify brain tumor therapeutic assets available for licensing and development. According to the announcement, the deal makes Innovate GBM the first outside organization to tap Lokahi’s proprietary asset-identification process, built on 14 university collaborations. GlucoTrack shares jumped 117.7% to $4.42 in pre-market trading